{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:24:26Z","timestamp":1788539066190,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexcr.2026.115127","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:32:56Z","timestamp":1784853176000},"page":"115127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the MAPK\/ERK signaling pathway: Mechanistic analysis of pexidartinib in overcoming adriamycin resistance in breast cancer"],"prefix":"10.1016","volume":"462","author":[{"given":"Rujue","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-0450","authenticated-orcid":false,"given":"Wufu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yexcr.2026.115127_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115127_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188310","article-title":"Mechanisms of acquired tumor drug resistance","volume":"1872","author":"Aleksakhina","year":"2019","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115127_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1023\/A:1008476528846","article-title":"Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells","volume":"9","author":"Kurowski","year":"1998","journal-title":"Ann. Oncol. : Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.yexcr.2026.115127_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2016.04.018","article-title":"Overcoming treatment resistance in cancer: current understanding and tactics","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115127_bib5","article-title":"EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion","volume":"12","author":"Chen","year":"2024"},{"issue":"16","key":"10.1016\/j.yexcr.2026.115127_bib6","first-page":"2610","article-title":"LPAL2 suppresses tumor growth and metastasis of hepatocellular carcinoma by modulating MMP9 expression","volume":"11","author":"Lin","year":"2022"},{"key":"10.1016\/j.yexcr.2026.115127_bib7","first-page":"1232","volume":"14","author":"Kim","year":"2022"},{"key":"10.1016\/j.yexcr.2026.115127_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176966","article-title":"Matrix metalloproteinases as the critical regulators of cisplatin response and tumor cell invasion","volume":"982","author":"Akhlaghipour","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115127_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chem."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115127_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1158\/0008-5472.CAN-23-3643","article-title":"The EP3-ZNF488 axis promotes self-renewal of glioma stem-like cells to induce resistance to tumor treating fields","volume":"85","author":"Chen","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","article-title":"The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115127_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188427","article-title":"Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors","volume":"1874","author":"Kes","year":"2020","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41420-026-02945-y","article-title":"Colorectal cancer-derived osteopontin rewires macrophages into a pro-metastatic M2 state via the PI3K\/AKT\/CSF1-CSF1R axis","volume":"12","author":"Liang","year":"2026","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115127_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/leu.2017.193","article-title":"Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma","volume":"32","author":"Wang","year":"2018","journal-title":"Leukemia"},{"issue":"Supplement_3","key":"10.1016\/j.yexcr.2026.115127_bib16","doi-asserted-by":"crossref","first-page":"iii56","DOI":"10.1093\/neuonc\/noz126.202","article-title":"P11.56 oncolytic virus and tumor microenvironment modulators an alliance to fight glioblastoma","volume":"21","author":"Puigdelloses","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.yexcr.2026.115127_bib17","first-page":"TPS465","volume":"34","author":"Wainberg","year":"2016"},{"key":"10.1016\/j.yexcr.2026.115127_bib18","article-title":"Inhibition of CSF1R and AKT by (\u00b1)-kusunokinin hinders breast cancer cell proliferation","volume":"129","author":"Rattanaburee","year":"2020","journal-title":"Biomed. Pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"S1","key":"10.1016\/j.yexcr.2026.115127_bib19","article-title":"A\u03b2 re-wires CSF1R-induced MAPK pathway activation in MMC microglia","volume":"20","author":"Bitarafan","year":"2024"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib20","article-title":"CSF1R inhibitor (PLX3397) alleviates experimental periodontitis by reducing macrophage senescence through the PI3K\/AKT\/FOXO1 signaling pathway","volume":"15","author":"Kang","year":"2025","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.yexcr.2026.115127_bib21","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-23-0576","article-title":"Effective reprogramming of patient-derived M2-Polarized glioblastoma-associated microglia\/macrophages by treatment with GW2580","volume":"29","author":"Fermi","year":"2023","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115127_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1078-0432.CCR-19-1486","article-title":"Colony-stimulating factor 1 receptor (CSF1R) activates AKT\/mTOR signaling and promotes T-Cell lymphoma viability","volume":"26","author":"Murga-Zamalloa","year":"2020","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115127_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137425","article-title":"Based on virtual screening methods and biological activity assessment, AK-968\/13030056 has been identified as a potential mTOR inhibitor","volume":"1302","author":"Yang","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.yexcr.2026.115127_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-025-03627-w","article-title":"Targeting serine synthesis pathway to reverse paclitaxel resistance in NSCLC with combination of paclitaxel and anlotinib","volume":"45","author":"Yu","year":"2026","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115127_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135084","article-title":"Multifunctional MIL-101 nanoparticles with Fenton-like reactions to Co-deliver LL-37 peptide and vancomycin for targeted NIR imaging and drug-resistant bacteria treatment","volume":"435","author":"Lai","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115127_bib26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/pro.2374","article-title":"Molecular basis of MAP kinase regulation","volume":"22","author":"Peti","year":"2013","journal-title":"Protein Sci. : Publ. Protein Soc."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115127_bib27","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12964-023-01170-9","article-title":"The emerging roles of MAPK-AMPK in ferroptosis regulatory network","volume":"21","author":"Wang","year":"2023","journal-title":"Cell Commun. Signal. : CCS"},{"issue":"19","key":"10.1016\/j.yexcr.2026.115127_bib29","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1073\/pnas.1821323116","article-title":"Cystine\/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance","volume":"116","author":"Lim","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115127_bib30","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/tox.23586","article-title":"PM(2) (.5) exposure-induced ferroptosis in neuronal cells via inhibiting ERK\/CREB pathway","volume":"37","author":"Xiong","year":"2022","journal-title":"Environ. Toxicol."},{"issue":"19","key":"10.1016\/j.yexcr.2026.115127_bib31","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.devcel.2024.09.004","article-title":"Dynamic death decisions: how mitochondrial dynamics shape cellular commitment to apoptosis and ferroptosis","volume":"59","author":"Khatun","year":"2024","journal-title":"Dev. Cell"},{"issue":"Pt 1","key":"10.1016\/j.yexcr.2026.115127_bib32","article-title":"Bacteria-driven mitoxantrone\/ferric ions liposomes to synergize chemotherapy, ferroptosis and immunotherapy for robust antitumor therapy","volume":"699","author":"Song","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.yexcr.2026.115127_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2024.07.006","article-title":"Role of mitochondrial reactive oxygen species in chemically-induced ferroptosis","volume":"223","author":"Song","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115127_bib34","article-title":"SUMOylation regulates tumorigenesis and progression: molecular mechanisms and therapeutic applications","volume":"4","author":"Wu","year":"2026"},{"key":"10.1016\/j.yexcr.2026.115127_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78069","article-title":"Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway","volume":"11","author":"Kim","year":"2022","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.yexcr.2026.115127_bib36","first-page":"2668","article-title":"Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability","volume":"20","author":"Chen","year":"2019"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115127_bib37","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.cellsig.2009.07.015","article-title":"Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK","volume":"21","author":"Kucharska","year":"2009","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115127_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41419-022-04775-z","article-title":"Interaction between macrophages and ferroptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib39","first-page":"24","article-title":"Harnessing ferroptosis for cancer therapy: mechanisms and therapeutic strategies","volume":"55","author":"Mouawad","year":"2026","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115127_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2644681","article-title":"Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"},{"key":"10.1016\/j.yexcr.2026.115127_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s13058-014-0431-9","article-title":"Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells","volume":"16","author":"Liu","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115127_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172244","article-title":"Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells","volume":"12","author":"Chewchuk","year":"2017","journal-title":"PLoS One"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:10:41Z","timestamp":1788538241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0014482726002442"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115127","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the MAPK\/ERK signaling pathway: Mechanistic analysis of pexidartinib in overcoming adriamycin resistance in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115127"}}